Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecubectedin (PM14) in Soft Tissue Sarcomas and Solid Tumors
NCT05146440Phase 2Recruiting
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Nov 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ecubectedin in soft tissue sarcoma (STS), solid tumor, sponsored by Spanish Group for Research on Sarcoma. Started Nov 2021; status: recruiting.
02
Drugs
ecubectedin
03
Conditions
soft tissue sarcoma (STS)solid tumor
Beyond the preview
Go deeper on NCT05146440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05146440.